Stay updated on Venetoclax Regimen to Prevent AML Relapse Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.

Latest updates to the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check38 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has updated the intervention details to include a verified status from the Institute of Hematology & Blood Diseases Hospital, China, indicating it is currently recruiting, while the previous type of intervention has been removed.SummaryDifference4%
- Check89 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Venetoclax Regimen to Prevent AML Relapse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.